Anthea Li's questions to Crinetics Pharmaceuticals Inc (CRNX) leadership • Q1 2025
Question
Anthea Li, on for Dennis Ding, requested an update on enrollment and follow-up in the long-term extension study for CAH and asked what would constitute a critical mass of data for a public update.
Answer
Dr. R. Struthers, CEO, confirmed that enrollment in the open-label extension (OLE) is ongoing but declined to provide specific numbers or timing for a data release. He emphasized the OLE's value in gathering real-world evidence and stated that data would be presented at a scientific meeting once a sufficient dataset is available.